CERTARA INC. - COMMON STOCK

11.01

12-March-25 15:45:00

15 minutes delayed

Stocks

+0.11

+1.01%

Today's range

10.82 - 11.24

ISIN

N/A

Source

NASDAQ

Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Biosimulation Software for Evaluating Regulatory Submissions

23 Jun 2021 18:00:00 By Nasdaq GlobeNewswire
Certara Appoints Dr. Carol Gallagher as New Independent Board Member

14 Jun 2021 07:00:01 By Nasdaq GlobeNewswire
Certara to Participate in the William Blair Growth Stock Conference and Jefferies Virtual Healthcare Conference

20 May 2021 07:00:01 By Nasdaq GlobeNewswire
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-oncology Therapies

13 May 2021 07:00:01 By Nasdaq GlobeNewswire
Certara Reports First Quarter 2021 Financial Results and Updates Full Year 2021 Guidance

06 May 2021 15:15:00 By Nasdaq GlobeNewswire
Certara Launches Secondary Intelligence™ Software to Predict Risk of Unwanted Side Effects of Drug Candidates Earlier

04 May 2021 17:15:00 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.